Skip to main content
SpringerLink
Log in

Histamine H2-Receptor Antagonists Versus Prostaglandins in the Treatment of Peptic Ulcer Disease

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Aenishanslin W, Barlocher C, Bernoulli R, Egger G, Eisner M, et al. Misoprostil und Cimetidin bei der Behandlung des Ulcus duodeni. Schweizer Medizinische Wochenschrift 115: 1225–1231, 1985

    CAS  Google Scholar 

  • Agrawal N, Roth S, Mahowald M, Montoya H, Robbins R, et al. Misoprostol coadministration heals aspirin-induced gastric lesions in rheumatoid arthritis patients. Gastroenterology 92: 1290, 1987

    Google Scholar 

  • Arakawa T, Fukuda T, Satoh H, Kohyashi K. Cimetidine increases gastric vulnerability through the induction of a deficiency of endogenous prostaglandins. Gastroenterology 90: 1330, 1986

    Google Scholar 

  • Arakawa T, Kitada K, Nakamura A, Satoh H, Yamada H, et al. Effect of long-term administration of misoprostol on epithelial cell growth in rat gastric mucosa. Gastroenterology 92: 1298, 1987

    Google Scholar 

  • Arnold R, Koop H, Schwarting H, Tuch K, Willemer B. Effect of acid inhibition on gastric endocrine cells. Scandinavian Journal of Gastroenterology 21 (Suppl. 125): 14–19, 1986

    Article  CAS  Google Scholar 

  • Barakat MH, Menon KN, Badawi AR. Cigarette smoking and duodenal ulcer healing. Digestion 29: 85–90, 1984

    Article  PubMed  CAS  Google Scholar 

  • Bardhan KD, Bose K, Hinchliffe RFC, Whittaker L, Morris P, et al. Enprostil versus ranitidine in duodenal ulcer. Gut 26: A1149, 1985

    Google Scholar 

  • Bardhan KD, Whittaker L, Hinchliffe RFC, Cleur K, Bose K. Trimoprostil vs cimetidine in duodenal ulcer. Gut 25: A580, 1984

    Article  Google Scholar 

  • Berkowitz JM, Adler SN, Sharp JT, Warner CW. Reduction of aspirin-induced gastroduodenal mucosal damage with ranitidine. Journal of Clinical Gastroenterology 8: 377–380, 1986

    Article  PubMed  CAS  Google Scholar 

  • Bertaccini G, Coruzzi G, Poli E, Adami M. Pharmacology of the novel H-antagonist famotidine: in vitro studies. Agents and Actions 19: 180–187, 1986

    Article  PubMed  CAS  Google Scholar 

  • Bianchi Porro G, Parente F. In Bianchi Porro G & Dajani EZ (Eds) Gastrointestinal cytoprotection by prostaglandins, pp. 39–46, Cortina International, Verona, 1987

  • Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons EM. Definition and antagonism of histamine H2-receptors. Nature 236: 385–390, 1972

    Article  PubMed  CAS  Google Scholar 

  • Black JW, Leff P, Shankley NP. Further analysis of anomalous pKb values for histamine H2-receptor antagonists on the mouse isolated stomach assay. British Journal of Pharmacology 86: 581–587, 1985

    Article  PubMed  CAS  Google Scholar 

  • Bolton JP, Cohen MM. Permeability effects of E2prostaglandins on canine gastric mucosa. Canadian Journal of Physiology and Pharmacology 57: 1082–1087, 1979

    Article  PubMed  CAS  Google Scholar 

  • Boyd EJS, Wormsley KG. Effects of loxtidine, a new histamine H2-receptor antagonist, on 24-hour gastric secretion in man. European Journal of Clinical Pharmacology 26: 443–447, 1984

    Article  PubMed  CAS  Google Scholar 

  • Boyd EJS, Wormsley KG. Gastrointestinal side-effects of prostaglandins. In Rainsford KD & Velo GP (Eds) Side effects of anti-inflammatory drugs, part 2, pp. 143–149, MTP Press, Lancaster, 1987

    Chapter  Google Scholar 

  • Branski D, Sharon P, Karmeli F, Rachmilewitz D. Effect of cimetidine on human gastric and duodenal prostanoid synthesis. Scandinavian Journal of Gastroenterology 19: 457–460, 1984

    PubMed  CAS  Google Scholar 

  • Brittain RT, Jack D, Reeves JJ, Stables R. Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an unsurmountable histamine H2-receptor blocking drug. British Journal of Pharmacology 85: 843–847, 1985

    Article  PubMed  CAS  Google Scholar 

  • Brogden RN, Heel RC, Speight TM, Avery GS. Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs 15: 93–131, 1978

    Article  PubMed  CAS  Google Scholar 

  • Campoli-Richards DM, Clissold SP. Famotidine: pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 32: 197–221, 1986

    Article  PubMed  CAS  Google Scholar 

  • Carling L, Almstrom C, Cronstedt J, Ekstrom P, Hagg S, et al. Comparison of enprostil and cimetidine in the treatment of duodenal ulcer. Scandinavian Journal of Gastroenterology 21 (Suppl. 120): 15, 1986

    Google Scholar 

  • Charlet N, Gallo-Torres HE, Bounameaux Y, Wills RJ. Prostaglandins and the protection of the gastroduodenal mucosa in humans: a critical review. Journal of Clinical Pharmacology 25: 564–582, 1985

    PubMed  CAS  Google Scholar 

  • Cheli R, Molinari F, Parodi MC. Cimetidine and cytoprotection. Scandinavian Journal of Gastroenterology 21 (Suppl. 121): 37–39, 1986

    Article  Google Scholar 

  • Cloud ML. Safety of nizatidine in clinical trials conducted in the USA and Europe. Scandinavian Journal of Gastroenterology 22 (Suppl. 136): 29–36, 1987

    Article  Google Scholar 

  • Cohen MM. Clinical evidence for gastroduodenal protection. In Cohen MM (Ed.) Biological protection with prostaglandins, vol. II, pp. 137–154, CRC Press Inc., Boca Raton, 1987

    Google Scholar 

  • Cohen MM. Role of endogenous prostaglandins in gastric secretion and mucosal defense. Clinical and Investigative Medicine 10: 226–231, 1987

    PubMed  CAS  Google Scholar 

  • Croker JR, Cotton PB, Boyle AC, Kinsella P. Cimetidine for peptic ulcer in patients with arthritis. Annals of the Rheumatic Diseases 39: 275–278, 1980

    Article  PubMed  CAS  Google Scholar 

  • Dajani EZ. Overview of the mucosal protective effects of miso-prostol in man. Prostaglandins 33 (Suppl. 117): 129, 1987

    Google Scholar 

  • Daly MJ, Humphrey JM, Stables R. Some in vitro and in vivo actions of the new histamine H2-receptor antagonist ranitidine. British Journal of Pharmacology 72: 49–54, 1981

    Article  PubMed  CAS  Google Scholar 

  • Daly MJ, Price BJ. Ranitidine and other H2-receptor antagonists: recent developments. In Ellis GP & West GB (Eds) Progress in medicinal chemistry, vol. 20, pp. 337–368, Elsevier Science Publishers, Amsterdam, 1983

    Chapter  Google Scholar 

  • Dammann HG, Huttemann W, Kalek HD, Rohner HG, Simon G. Comparative clinical trial of enprostil and ranitidine in the treatment of gastric ulcer. American Journal of Medicine 81 (Suppl. 2A): 80–84, 1986

    Article  PubMed  CAS  Google Scholar 

  • Dawson J, Richards DA, Stables R, Dixon GT, Cockel R. Ranitidine: pharmacology and clinical use. Journal of Clinical and Hospital Pharmacy 8: 1–13, 1983

    PubMed  CAS  Google Scholar 

  • Delaney JP, Michel HM, Bond J. Cimetidine and gastric blood flow. Surgery 84: 190–193, 1978

    PubMed  CAS  Google Scholar 

  • Dickson B, Peace KE. The effect of acute treatment with misoprostol, cimetidine and placebo on spontaneous duodenal ulcer relapse. Gastroenterology 92: 1370, 1987

    Google Scholar 

  • Dodd DC, Port CD, Deslex P, Regnier B, Sanders P, et al. Two-year evaluation of misoprostol for carcinogenicity in CD Sprague-Dawley rats. Toxicologie Pathology 15: 125–133, 1987

    Article  CAS  Google Scholar 

  • Eastwood GL, Quimby GF. Effect of chronic cimetidine ingestion on fundic and antral epithelial proliferation in the rat. Digestive Diseases and Sciences 28: 61–64,1983

    Article  PubMed  CAS  Google Scholar 

  • Editorial. Too many H2antagonists. Lancet 1: 28–29, 1988

    Google Scholar 

  • Fich A, Arber N, Okon E, Zajicek G, Rachmilewitz D. Effect of chronic misoprostol ingestion on rat gastric morphology and cell turnover. Archives of Toxicology 61: 314–317, 1988

    Article  PubMed  CAS  Google Scholar 

  • Fich A, Arber N, Sestieri M, Zajicek G, Rachmilewitz D. Effect of misoprostol and cimetidine on gastric cell labeling index. Gastroenterology 89: 57–61, 1985

    PubMed  CAS  Google Scholar 

  • Fich A, Goldin E, Zimmerman J, Ligumsky M, Rachmilewitz D. Comparison of misoprostol and cimetidine in the treatment of duodenal ulcer. Israel Journal of Medical Sciences 21: 102–106, 1985

    PubMed  CAS  Google Scholar 

  • Flemstrom G. Gastroduodenal mucosal secretion of bicarbonate and mucus. American Journal of Medicine 81 (Suppl. 2A): 18–22, 1986

    Article  PubMed  CAS  Google Scholar 

  • Forrest JAH, Fettes MR, McLoughlin GP, Heading RC. Effect of long-term cimetidine on gastric acid secretion, serum gastrin, and gastric emptying. Gut 20: 404–407, 1979

    Article  PubMed  CAS  Google Scholar 

  • Gaskill HV, Sirinek KR, Levine BA. 16,16-dimethyl prostaglandin E2reverses focal mucosal ischemia associated with stress ulcers. Journal of Surgical Research 37: 83–88, 1984

    Article  PubMed  CAS  Google Scholar 

  • Giraud AS, Walsh JH, Soll AH. Prostanoids of the PGE2series differentially affect gastrin release from canine G-cells in short term culture. Gastroenterology 90: 1428, 1986

    Google Scholar 

  • Goa KL, Monk JP. Enprostil: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of peptic ulcer disease. Drugs 34: 539–559, 1987

    Article  PubMed  CAS  Google Scholar 

  • Goldin E, Ligumsky M, Fich A, Eliakim R, Zimmerman J, et al. Effect of drug therapy and ulcer healing on endogenous gastric prostanoid synthesis in duodenal ulcer patients. Gastroenterology 88: 1398, 1985

    Google Scholar 

  • Guslandi M. Alkali secretion by the human stomach: effect of H2blockers. American Journal of Physiology 249: G649, 1985

    PubMed  CAS  Google Scholar 

  • Guth PH, Paulsen G, Nagata H. Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat: effect of prostaglandin cytoprotection. Gastroenterology 87: 1083–1090, 1984

    PubMed  CAS  Google Scholar 

  • Hakanson R, Blom H, Carlsson E, Larsson H, Ryberg B, et al. Hypergastrinaemia produces trophic effects in stomach but not in pancreas and intestines. Regulatory Peptides 13: 225–233, 1986

    Article  PubMed  CAS  Google Scholar 

  • Halter F, Reinhart WH, Koelz HR, Meyrat P, Lentze MJ, et al. 16,16-dimethyl prostaglandin E: stimulates growth and maturation of rat gastric and small-intestinal mucosa. Scandinavian Journal of Gastroenterology 19 (Suppl. 92): 178–183, 1984

    CAS  Google Scholar 

  • Hansky J, Stern AI, Korman MG, Waugh J. Effects of long-term cimetidine on serum gastrin in duodenal ulcer. Digestive Diseases and Sciences 24: 468–470, 1979

    Article  PubMed  CAS  Google Scholar 

  • Hawkey CJ, Rampton DS. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease or treatment? Gastroenterology 89: 1162–1188, 1985

    PubMed  CAS  Google Scholar 

  • Hawkey CJ, Walt RP. Prostaglandins for peptic ulcer: a promise unfulfilled. Lancet 2: 1084–1087, 1986

    Article  PubMed  CAS  Google Scholar 

  • Hawkey CJ, Walt RP. Misoprostol, smoking, and duodenal ulcer healing rates. Lancet 1: 393, 1987

    Article  PubMed  CAS  Google Scholar 

  • Hetzel DJ, Shearman DJC, Korman MG, Hansky J, Ellard J, et al. Misoprostol, a prostaglandin E, methyl ester in the treatment of gastric and duodenal ulcers. Australian and New Zealand Journal of Medicine 15: 547, 1985

    Google Scholar 

  • Hitanant S, Tuchinda P, Kachintorn U, Petchroungrong B, Plenqvanit U, et al. A comparison of prostaglandin E2analogue (enprostil) and ranitidine in the treatment of duodenal ulcer. Gastroenterology 92: 1436, 1987

    Google Scholar 

  • Hogan DL, Thomas FJ, I sen berg JI. Cimetidine decreases aspirin-induced gastric mucosal damage in humans. Alimentary Pharmacology and Therapeutics 1: 383–390, 1987

    Article  PubMed  CAS  Google Scholar 

  • Hui WM, Urn SK, Ho J, Ng WMT, Lui I, et al. Chronic antral gastritis in duodenal ulcer. Gastroenterology 91: 1095–1101, 1986

    PubMed  CAS  Google Scholar 

  • Inoue M. Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan. Drugs 35 (Suppl. 3): 114–119, 1988

    Article  PubMed  Google Scholar 

  • Isenberg JI, Hogan DL, Koss MA, Selling JA. Human duodenal mucosal bicarbonate secretion. Gastroenterology 91: 370–378, 1986

    PubMed  CAS  Google Scholar 

  • Jentjens T, Smits HL, Strous GJ. 16,16-dimethyl prostaglandin E2stimulates galactose and glucosamine but not serine incorporation in rat gastric mucous cells. Gastroenterology 87: 409–416, 1984

    PubMed  CAS  Google Scholar 

  • Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 28: 1120–1127, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kakei M, Ohara S, Ishihara K, Okabe H, Hotta K. Effect of cimetidine on gastric mucus glycoprotein biosynthesis. Digestion 34: 122–126, 1986

    Article  PubMed  Google Scholar 

  • Kimmey MB, Silverstein FE, Saunders DR, Chapman RC. Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine. Digestive Diseases and Sciences 32: 851–856, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kohn A, Suriano G, Prantera C, Annibale B, della Fave G. Hypergastrinaemia after long-term H2-blocker treatment. Lancet 2: 1466–1467, 1987

    Article  PubMed  CAS  Google Scholar 

  • Konturek SJ, Kwiecien N, Obtulowicz W, Polanski M, Kopp B, et al. Comparison of prostaglandin E2and ranitidine in prevention of gastric bleeding by aspirin in man. Gut 24: 89–93, 1983

    Article  PubMed  CAS  Google Scholar 

  • Korman MG, Hansky J, Eaves ER, Schmidt GT. Influence of cigarette smoking on healing and relapse of duodenal ulcer disease. Gastroenterology 85: 871–874, 1983

    PubMed  CAS  Google Scholar 

  • Lacy ER. Prostagland ins and histological changes in the gastric mucosa. Digestive Diseases and Sciences 30: 83S–94S, 1985

    Article  PubMed  CAS  Google Scholar 

  • Lam SK. Prostaglandins for duodenal ulcer. Clinical and Investigative Medicine 10: 232–237, 1987

    PubMed  CAS  Google Scholar 

  • Lam SK, Lau WY, Choi TK, Lai CL, Lok ASF, et al. Prostaglandin E1(misoprostol) overcomes the adverse effects of chronic cigarette smoking on duodenal ulcer healing. Digestive Diseases and Sciences 31: 68S–74S, 1986

    Article  PubMed  CAS  Google Scholar 

  • Lanza FL, Aspinall RL, Swabb EA, Davis RE, Rack MF, et al. Double-blind, placebo-controlled endoscopie comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 95: 289–294, 1988

    PubMed  CAS  Google Scholar 

  • Larsson H, Carlsson E, Mattsson H, Lundell L, Sundler F, et al. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Gastroenterology 90: 391–399, 1986

    PubMed  CAS  Google Scholar 

  • Lauritsen K, Havelund T, Laursen LS, Bytzer P, Kjaergaard J, et al. Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial. British Medical Journal 294: 932–934, 1987

    Article  PubMed  CAS  Google Scholar 

  • Lauritsen K, Laursen LS, Havelund T, Bytzer P, Svendsen LB, et al. Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial. British Medical Journal 292: 864–866, 1986

    Article  PubMed  CAS  Google Scholar 

  • Lee SP, Nicholls JF, Robertson AM. Effects of trimoprostil, a prostaglandin E2analogue, on human gastric acid secretion and soluble mucin output. European Journal of Clinical Investigation 17: 1–6, 1987

    Article  PubMed  CAS  Google Scholar 

  • Leung FW, Robert A, Guth PH. Gastric mucosal blood flow in rats after administration of 16,16-dimethyI prostaglandin E2at a cytoprotective dose. Gastroenterology 88: 1948–1953, 1985

    PubMed  CAS  Google Scholar 

  • Lewis JH. Summary of the 30th meeting of the Food and Drug Administration Gastrointestinal Drugs Advisory Committee, January 16–17, 1986. American Journal of Gastroenterology 81: 495–498, 1986

    PubMed  CAS  Google Scholar 

  • Lezoche E, Vagni V, D’Alessandro MD, Mariani P, Carlei F, et al. Action of famotidine and ranitidine on prostaglandin E2content of fundic and duodenal mucosa in duodenal ulcer patients. Drugs in Experimental and Clinical Research 8: 655–658, 1987

    Google Scholar 

  • Lin TM, Evans DC, Warrick MW, Pioch RP. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs. Journal of Pharmacology and Experimental Therapeutics 239: 406–410, 1986

    PubMed  CAS  Google Scholar 

  • Malchow-Moller A. Treatment of peptic ulcer induced by non-steroidal anti-inflammatory drugs. Scandinavian Journal of Gastroenterology 22 (Suppl. 127): 87–91, 1987

    Article  Google Scholar 

  • Malinowska DH, Sachs G. Cellular mechanisms of acid secretion. Clinics in Gastroenterology 13: 309–326, 1984

    PubMed  CAS  Google Scholar 

  • Manniche C, Malchow-Moller A, Andersen JR, Pedersen C, Hansen TM, et al. Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut 28: 226–229, 1987

    Article  PubMed  CAS  Google Scholar 

  • Mazure PA. Comparative efficacy of misoprostol and cimetidine in the treatment of acute duodenal ulcer. American Journal of Medicine 83 (Suppl. 1A): 22–26, 1987

    Article  PubMed  CAS  Google Scholar 

  • Miller TA. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. American Journal of Physiology 245: G601–G623, 1983

    PubMed  CAS  Google Scholar 

  • Mohamed S, Nadijcka MD, Hanson VA. Wound healing properties of cimetidine in vitro. Drug Intelligence and Clinical Pharmacy 20: 973–975, 1986

    PubMed  CAS  Google Scholar 

  • Monk JP, Clissold SP. Misoprostol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease. Drugs 33: 1–30, 1987

    Article  PubMed  CAS  Google Scholar 

  • Morgan AG, McAdam WAF, Pacsoo C. Comparison between enprostil and ranitidine in the treatment of gastric ulceration and subsequent follow up. Gut 26: Al 149, 1985

    Google Scholar 

  • Morris GP. Prostaglandins and cellular restitution in the gastric mucosa. American Journal of Medicine 81 (Suppl. 2A): 23–29, 1986

    Article  PubMed  CAS  Google Scholar 

  • Muller P, Biewer R, Bouzo F, Dammann HG, Schutz E, et al. Ranitidine heals gastroduodenal lesions associated with chronic NOSAC therapy in rheumatic patients. Gastroenterology 92: 1543, 1987

    Google Scholar 

  • Muller P, Dammann HG, Simon B. Therapie und Pravention peptischer Lasionen durch Prostagland ine. Zeitschrift für Gastroenterologie 25 (Suppl. 3): 166–174, 1987

    PubMed  Google Scholar 

  • Muller P, Kather H, Dammann HG, Simon B. Heilen Prostaglandine in niedriger zytoprotektiver Dosierung peptische Ulzera? Münchener Medizinische Wochenschrift 124: 43–44, 1982

    Google Scholar 

  • Nicholson PA. A multicenter international controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in outpatients. Digestive Diseases and Sciences 30 (Suppl.): 171S–177S, 1985

    Article  PubMed  CAS  Google Scholar 

  • O’Brien PE, Carter DC. Effect of gastric secretory inhibitors on the gastric mucosal barrier. Gut 16: 437–442, 1975

    Article  PubMed  Google Scholar 

  • O’Brien P, Schultz C, Gannon B, Browning J. Protective effects of the synthetic prostaglandin enprostil on the gastric micro-vasculature after ethanol injury in the rat. American Journal of Medicine 81 (Suppl. 2A): 12–17, 1986

    Article  PubMed  Google Scholar 

  • O’Keefe SJD, Spitaels JM, Mannion G, Naiker N. Misoprostol, a synthetic prostaglandin Et analogue, in the treatment of duodenal ulcers. South African Medical Journal 67: 321–324, 1985

    PubMed  Google Scholar 

  • Penston JG, Johnston DA, Wormsley KG. Trimoprostil decreases acid disappearance from the human stomach. Current Medical Research and Opinion 10: 308–312, 1986

    Article  PubMed  CAS  Google Scholar 

  • Penston JG, Johnston DA, Wormsley KG. The effects of rioprostil on gastric emptying and intragastric acidity. Hepatogastroenterology 33: 120–122, 1986

    PubMed  CAS  Google Scholar 

  • Penston JG, Wormsley KG. Adverse reactions and interactions with H2receptor antagonists. Medical Toxicology 1: 192–216, 1986

    PubMed  CAS  Google Scholar 

  • Penston JG, Wormsley KG. Achlorhydria: hypergastrinaemia: carcinoids - a flawed hypothesis? Gut 28: 488–505, 1987

    Article  PubMed  CAS  Google Scholar 

  • Pounder RE. Histamine H-receptor antagonists and gastric acid secretion. Pharmacology and Therapeutics 26: 221–234, 1984

    Article  PubMed  CAS  Google Scholar 

  • Price AH, Brogden RN. Nizatidine: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Drugs 36: 521–539, 1988

    Article  PubMed  CAS  Google Scholar 

  • Quatrini M, Basilico G, Bianchi PA. Treatment of ‘cimetidine-resistant’ chronic duodenal ulcers with ranitidine or cimetidine: a randomised multicentre study. Gut 25: 1113–1117, 1984

    Article  PubMed  CAS  Google Scholar 

  • Quinton A, Goldfain D, Weber F, Briaud M, Plane D, et al. Gastric ulcer healing: rioprostil versus ranitidine. Gastroenterology 92: 1586, 1987

    Google Scholar 

  • Rachmilewitz D. Efficacy of prostanoids in the treatment of gastric ulcer. Clinical and Investigative Medicine 10: 238–242, 1987

    PubMed  CAS  Google Scholar 

  • Rachmilewitz D. The role of H2-receptor antagonists in the prevention of NSAID-induced gastrointestinal damage. Alimentary Pharmacology and Therapeutics 2 (Suppl.): 65–73, 1988

    Article  PubMed  Google Scholar 

  • Rachmilewitz D, Chapman JW, Nicholson PA. A multicentre international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients. Digestive Diseases and Sciences 31: 75S–80S, 1986

    Article  PubMed  CAS  Google Scholar 

  • Reeves JJ, Stables R. The antisecretory profile of action of the H2-receptor antagonists famotidine, ranitidine and L-643,441 on the rat isolated gastric mucosa. Agents and Actions 20: 22–28, 1987

    PubMed  CAS  Google Scholar 

  • Robert A. Cytoprotection by prostaglandins. Gastroenterology 77: 761–767, 1979

    PubMed  CAS  Google Scholar 

  • Robert A. Cytoprotection and prostaglandins. Klinische Wochenschrift 64 (Suppl. VII): 40–43, 1986

    PubMed  CAS  Google Scholar 

  • Ryan JR, Vargas R, Clay GA, McMahon FG. Role of misoprostol in reducing aspirin-induced gastrointestinal blood loss in arthritic patients. American Journal of Medicine 83 (Suppl. 1A): 41–44, 1987

    Article  PubMed  CAS  Google Scholar 

  • Scholtholt J, Bickel M, Herling AN. A review of the animal pharmacology of roxatidine acetate. Drugs 35 (Suppl. 3): 30–40, 1988

    Article  PubMed  CAS  Google Scholar 

  • Sevelius H. Overall safety of enprostil in clinical studies. Italian Journal of Gastroenterology 19 (Suppl.): 25S, 1987

    Google Scholar 

  • Sewing KF, Beil W, Hannemann H. Comparative pharmacology of histamine H2-receptor antagonists. Drugs 35 (Suppl. 3): 25–29, 1988

    Article  PubMed  CAS  Google Scholar 

  • Sewing KF, Hannemann H. Interaction of ranitidine and famotidine with guinea pig-isolated parietal cells. Pharmacology 33: 274–278, 1986

    Article  PubMed  CAS  Google Scholar 

  • Shield MJ. Interim results of a multicenter international comparison of misoprostol and cimetidine in the treatment of outpatients with benign gastric ulcers. Digestive Diseases and Sciences 30 (Suppl.): 178S–184S, 1985

    Article  PubMed  CAS  Google Scholar 

  • Silen W. What is cytoprotection of the gastric mucosa? Gastroenterology 94: 232–235, 1988

    PubMed  CAS  Google Scholar 

  • Silverstein FE, Kimmey MB, Saunders DR, Surawicz CM, Willson RA, et al. Gastric protection by misoprostol against l,300mg of aspirin. American Journal of Medicine 83 (Suppl. 1A): 32–35, 1987

    Article  PubMed  CAS  Google Scholar 

  • Simjee AE, Spitaels JM, Pettengell KE, Manion GL, van Leehoff H. Comparative trial of misoprostol and ranitidine in the treatment of duodenal ulcers. South African Medical Journal 70: 49, 1986

    Google Scholar 

  • Simon B, Dammann HG, Muller P. Gastroduodenal tolerability of nonsteroidal antiinflammatory agents in man: endoscopic comparative studies with antiulcer drugs. Gastroenterology 90: 1635, 1986

    Google Scholar 

  • Simon B, Dammann HG, Muller P. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing. Klinische Wochenschrift 64 (Suppl. VII): 44–46, 1986

    PubMed  Google Scholar 

  • Simon B, Dammann HG, Muller P. Can non-antisecretory doses of prostaglandins prevent mucosal damage in nonsteroidal anti-inflammatory drugs. In Domschke & Dammann (Eds) Prostaglandins and leukotrienes in gastrointestinal diseases, pp. 153–160, Springer Verlag, Berlin, 1988

    Chapter  Google Scholar 

  • Soll AH. Mechanisms of action of antisecretory drugs. Scandinavian Journal of Gastroenterology 21 (Suppl. 125): 1–6, 1986

    Article  CAS  Google Scholar 

  • Soll AH. Review: antisecretory drugs: cellular mechanisms of action. Alimentary Pharmacology and Therapeutics 1: 77–89, 1987

    Article  PubMed  CAS  Google Scholar 

  • Somogyi A, Muirhead M. Pharmacokinetic interactions of cimetidine 1987. Clinical Pharmacokinetics 12: 321–366, 1987

    Article  PubMed  CAS  Google Scholar 

  • Sontag S, Graham DY, Belsito A, Weiss J, Farley A, et al. Cimetidine, cigarette smoking and recurrence of duodenal ulcer. New England Journal of Medicine 311: 689–693, 1984

    Article  PubMed  CAS  Google Scholar 

  • Stiel D, Ellard KT, Hills LJ, Brooks PM. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. American Journal of Medicine 81 (Suppl. 2A): 54–58, 1986

    Article  PubMed  CAS  Google Scholar 

  • Svendsen LB, Hansen OH, Larsen JK, Pedersen T, Johansen A. Effect of cimetidine on gastric mucosal cell proliferation in man. Scandinavian Journal of Gastroenterology 21: 1271–1274, 1986

    Article  PubMed  CAS  Google Scholar 

  • Svendsen LB, Jorgensen FS, Hansen OH, Johansen A, Horn T, et al. Influence of the prostaglandin Eanalogue rioprostil on the human gastric mucosa. Digestion 37: 29–34, 1987

    Article  PubMed  CAS  Google Scholar 

  • Walt RP, Long RG, Logan RFA, Somerville KW, Langman MJS, et al. Double-blind clinical trial comparing nocte enprostil with ranitidine in duodenal ulcer. Gastroenterology 90: 1683, 1986

    Google Scholar 

  • Walt RP, Pounder RE, Hawkey CJ, Santana IA, Somerville KW, et al. Twenty-four hour intragastric acidity and clinical trial of bedtime enprostil 70mg compared with ranitidine 300mg in duodenal ulcer. Alimentary Pharmacology and Therapeutics 1: 161–166, 1987

    Article  PubMed  CAS  Google Scholar 

  • Waterbury LD, Mahoney JM, Peak TM, Cohn RG, Garay GL. Stimulatory effect of enprostil, an anti-ulcer prostaglandin, on gastric mucus secretion. American Journal of Medicine 81 (Suppl. 2A): 30–33, 1986

    Article  PubMed  CAS  Google Scholar 

  • Watkinson G, Hopkins A, Akbar FA. The therapeutic efficacy of misoprostol in peptic ulcer disease. Postgraduate Medical Journal 64 (Suppl. 1): 60–73, 1988

    Article  PubMed  Google Scholar 

  • Wildeman RA. Focus on misoprostol: review of worldwide safety data. Clinical and Investigative Medicine 10: 243–245, 1987

    PubMed  CAS  Google Scholar 

  • Williams GM. Definition of a human cancer hazard. In Butter-worth BE & Slaga TJ (Eds) Nongenotoxic mechanisms in carcinogenesis, pp. 367–380, C ld Spring Harbor Laboratory, 1987

    Google Scholar 

  • Wilson DE. Clinical experience with misoprostol in the treatment of peptic ulcer disease. In Bianchi Porro G & Dajani EZ (Eds) Gastrointestinal cytoprotection by prostaglandins, pp. 33–38, Cortina International, Verona, 1987

    Google Scholar 

  • Winters L. Comparison of enprostil and cimetidine in active duodenal ulcer disease. American Journal of Medicine 81 (Suppl. 2A): 69–74, 1986

    Article  PubMed  CAS  Google Scholar 

  • Wormsley KG. Gastric and duodenal ulcer: the same disease? In Fisher RS (Ed.) Peptic ulcer disease: an update, pp. 231–259, Biomedical Information Corp., New York, 1979

    Google Scholar 

  • Wormsley KG. Assessing the safety of drugs for the long-term treatment of peptic ulcers. Gut 25: 1416–1423, 1984

    Article  PubMed  CAS  Google Scholar 

  • Wormsley KG. Aetiology of ulcers. Bailliere’s Clinical Gastroenterology 2: 555–571, 1988

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ninewells Hospital, Ninewells, Dundee, DD2 1UB, Scotland

    J. G. Penston &  K. G. Wormsley

Authors
  1. J. G. Penston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. G. Wormsley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Penston, J.G., Wormsley, K.G. Histamine H2-Receptor Antagonists Versus Prostaglandins in the Treatment of Peptic Ulcer Disease. Drugs 37, 391–401 (1989). https://doi.org/10.2165/00003495-198937040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198937040-00001

Keywords

Search

Navigation